# A "Window Trial" on Curcumin for Invasive Breast Cancer Primary Tumors

> **NCT03980509** · PHASE1 · COMPLETED · sponsor: **Medical University of South Carolina** · enrollment: 22 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** Curcumin

## Key facts

- **NCT ID:** NCT03980509
- **Lead sponsor:** Medical University of South Carolina
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-01-29
- **Primary completion:** 2022-03-24
- **Final completion:** 2023-03-24
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2025-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03980509

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03980509, "A "Window Trial" on Curcumin for Invasive Breast Cancer Primary Tumors". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT03980509. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*